tiprankstipranks
Neuren Pharmaceuticals Limited (AU:NEU)
ASX:NEU
Australian Market
NEU
Neuren Pharmaceuticals Limited
RESEARCH TOOLSreports
Want to see AU:NEU full AI Analyst Report?

Neuren Pharmaceuticals Limited (NEU) Stock News & Sentiment

281 Followers
Neuren Advances NNZ-2591 Into Phase 3 Extension, Deepening Its Rare-Disease Pipeline
Premium
Company Announcements
Neuren Advances NNZ-2591 Into Phase 3 Extension, Deepening Its Rare-Disease Pipeline
1d ago
NURPF
Neuren launches Investor Hub to bolster engagement as neurological pipeline advances
Premium
Company Announcements
Neuren launches Investor Hub to bolster engagement as neurological pipeline advances
12d ago
Neuren Pharmaceuticals Updates Daily On‑Market Share Buy‑Back Activity
Premium
Company Announcements
Neuren Pharmaceuticals Updates Daily On‑Market Share Buy‑Back Activity
12d ago
Neuren Rides 20% DAYBUE Sales Growth and Strong STIX Launch in Q1 2026
Premium
Company Announcements
Neuren Rides 20% DAYBUE Sales Growth and Strong STIX Launch in Q1 2026
17d ago
Neuren Updates Market on Ongoing On-Market Share Buy-Back
Premium
Company Announcements
Neuren Updates Market on Ongoing On-Market Share Buy-Back
18d ago
Neuren Pharmaceuticals Outlines Procedures for Virtual Shareholder Meeting
Premium
Company Announcements
Neuren Pharmaceuticals Outlines Procedures for Virtual Shareholder Meeting
30d ago
Neuren Sets Hybrid 2026 AGM, Puts Director Re-election to Shareholder Vote
Premium
Company Announcements
Neuren Sets Hybrid 2026 AGM, Puts Director Re-election to Shareholder Vote
30d ago
More AU:NEU News >

NEU News on the Web

Neuren Advances NNZ-2591 Into Phase 3 Extension, Deepening Its Rare-Disease Pipeline
TipRanks News
Bullish
Rise and Shine: Everything you need to know before the ASX opens
StockHead
Bullish
Biocurious: Emerging from a capital drought, biotech IPOs bloom again
StockHead
Neutral
Analysts’ Top Healthcare Picks: Neuren Pharmaceuticals Limited (NURPF), Design Therapeutics (DSGN)
TipRanks News
Bullish
Dr Boreham#8217;s Crucible: Neuren looks beyond Rett as Daybue royalties surge
StockHead
Bullish
Neuren launches Investor Hub to bolster engagement as neurological pipeline advances
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Neuren Pharmaceuticals Limited (OtherNURPF), Astrana Health (ASTH) and Pacific Biosciences (PACB)
TipRanks News
Bullish
Why Neuren Pharmaceuticals (ASX:NEU) Is Up 6.3% After Record DAYBUE Royalties And Strong STIX Launch – And What's Next
Simply Wall St
Neutral

News Score - Last 7 Days

Very Positive
AU:NEU
Sector Average
Media Buzz
This Week5 articles
Weekly Average3.75 articles
News Sentiment
This Week100%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:NEU’s Media Buzz Sentiment?
5 articles about AU:NEU were published this week. In an average week, 3.75 articles are published.
    What is AU:NEU’s weekly average amount of articles?
    In an average week, 3.75 articles about AU:NEU are published.
      What is AU:NEU’s News Sentiment?
      100% of articles about AU:NEU were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week